Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Buchanan

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Pharmacoeconomics|May 23, 2018
The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case StudyJosé Leal, Stefania Manetti, James Buchanan
Pharmacogenomics|November 19, 2013
Issues surrounding the health economic evaluation of genomic technologiesJames Buchanan, Sarah Wordsworth, Anna Schuh
Applied Health Economics and Health Policy|April 28, 2025
The Health Economics of Genomic Technologies: A Growing Evidence Base on ValueJames Buchanan, Ilias Goranitis, Deirdre Weymann
Pharmacoeconomics|March 6, 2019
Correction to: The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case StudyJosé Leal, Stefania Manetti, James Buchanan
BMJ Open|November 13, 2015
Evidence used in model-based economic evaluations for evaluating pharmacogenetic and pharmacogenomic tests: a systematic review protocolJaime L Peters, Chris Cooper, James Buchanan
Journal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology|December 17, 2008
Radiographic cardiac size in cats and dogs with heartworm disease compared with reference values using the vertebral heart scale method: 53 casesAnnette Litster, Clarke Atkins, Rick Atwell, et al.
Drug Safety|June 12, 2026
A Large Language Model for Extracting Post-marketing Adverse Drug Events from Clinical Notes in the Electronic Health RecordDana Ludwig, Michelle Wang, James Buchanan, et al.
Health and Quality of Life Outcomes|December 13, 2023
QALYs and rare diseases: exploring the responsiveness of SF-6D, EQ-5D-5L and AQoL-8D following genomic testing for childhood and adult-onset rare genetic conditions in AustraliaTianxin Pan, You Wu, James Buchanan, et al.
Therapeutic Innovation & Regulatory Science|July 19, 2021
A New Paradigm for Safety Data Signal Detection and Evaluation Using Open-Source Software Created by an Interdisciplinary Working GroupJames Buchanan, Mengchun Li, Xiao Ni, et al.
Plos One|January 6, 2011
Cost-effectiveness of pre-referral antimalarial, antibacterial, and combined rectal formulations for severe febrile illnessJames Buchanan, Borislava Mihaylova, Alastair Gray, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Pharmacoeconomics|May 23, 2018
The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case StudyJosé Leal, Stefania Manetti, James Buchanan
Pharmacogenomics|November 19, 2013
Issues surrounding the health economic evaluation of genomic technologiesJames Buchanan, Sarah Wordsworth, Anna Schuh
Applied Health Economics and Health Policy|April 28, 2025
The Health Economics of Genomic Technologies: A Growing Evidence Base on ValueJames Buchanan, Ilias Goranitis, Deirdre Weymann
Pharmacoeconomics|March 6, 2019
Correction to: The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case StudyJosé Leal, Stefania Manetti, James Buchanan
BMJ Open|November 13, 2015
Evidence used in model-based economic evaluations for evaluating pharmacogenetic and pharmacogenomic tests: a systematic review protocolJaime L Peters, Chris Cooper, James Buchanan
Journal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology|December 17, 2008
Radiographic cardiac size in cats and dogs with heartworm disease compared with reference values using the vertebral heart scale method: 53 casesAnnette Litster, Clarke Atkins, Rick Atwell, et al.
Drug Safety|June 12, 2026
A Large Language Model for Extracting Post-marketing Adverse Drug Events from Clinical Notes in the Electronic Health RecordDana Ludwig, Michelle Wang, James Buchanan, et al.
Health and Quality of Life Outcomes|December 13, 2023
QALYs and rare diseases: exploring the responsiveness of SF-6D, EQ-5D-5L and AQoL-8D following genomic testing for childhood and adult-onset rare genetic conditions in AustraliaTianxin Pan, You Wu, James Buchanan, et al.
Therapeutic Innovation & Regulatory Science|July 19, 2021
A New Paradigm for Safety Data Signal Detection and Evaluation Using Open-Source Software Created by an Interdisciplinary Working GroupJames Buchanan, Mengchun Li, Xiao Ni, et al.
Plos One|January 6, 2011
Cost-effectiveness of pre-referral antimalarial, antibacterial, and combined rectal formulations for severe febrile illnessJames Buchanan, Borislava Mihaylova, Alastair Gray, et al.
Pageof 9